Hillstream BioPharma, Inc.

HILS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$12-$9-$8-$2
Dep. & Amort.$0$0$1,569$1
Deferred Tax$0$0$0-$1
Stock-Based Comp.$1$1$1$1
Change in WC$0-$0-$1$1
Other Non-Cash$1$1-$1,567-$1
Operating Cash Flow-$11-$7-$7-$1
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$12$14$0
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$4$12$13$1
Financing Cash Flow$4$12$13$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$7$4$7-$0
Supplemental Information
Beg. Cash$11$7$0$0
End Cash$4$11$7$0
Free Cash Flow-$11-$7-$7-$1
Hillstream BioPharma, Inc. (HILS) Financial Statements & Key Stats | AlphaPilot